These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23219943)

  • 1. Equilibrium-dependent bisphosphonate interaction with crystalline bone mineral explains anti-resorptive pharmacokinetics and prevalence of osteonecrosis of the jaw in rats.
    Hokugo A; Sun S; Park S; McKenna CE; Nishimura I
    Bone; 2013 Mar; 53(1):59-68. PubMed ID: 23219943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.
    Hokugo A; Christensen R; Chung EM; Sung EC; Felsenfeld AL; Sayre JW; Garrett N; Adams JS; Nishimura I
    J Bone Miner Res; 2010 Jun; 25(6):1337-49. PubMed ID: 20200938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.
    Park S; Kanayama K; Kaur K; Tseng HC; Banankhah S; Quje DT; Sayre JW; Jewett A; Nishimura I
    J Biol Chem; 2015 Jul; 290(28):17349-66. PubMed ID: 26013832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
    Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
    Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory and necrotic effects of minodronate, a nitrogen-containing bisphosphonate, in mice.
    Kiyama T; Okada S; Tanaka Y; Kim S; Bando K; Hasegawa M; Yamaguchi K; Takano-Yamamoto T; Sasaki K; Sugawara S; Endo Y
    Tohoku J Exp Med; 2013 Jul; 230(3):141-9. PubMed ID: 23822921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.
    Aguirre JI; Akhter MP; Kimmel DB; Pingel JE; Williams A; Jorgensen M; Kesavalu L; Wronski TJ
    J Bone Miner Res; 2012 Oct; 27(10):2130-43. PubMed ID: 22623376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.
    Takaoka K; Yamamura M; Nishioka T; Abe T; Tamaoka J; Segawa E; Shinohara M; Ueda H; Kishimoto H; Urade M
    PLoS One; 2015; 10(12):e0144355. PubMed ID: 26659123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates].
    Endo Y; Funayama H; Yamaguchi K; Monma Y; Yu Z; Deng X; Oizumi T; Shikama Y; Tanaka Y; Okada S; Kim S; Kiyama T; Bando K; Shima K; Suzuki H; Takahashi T
    Yakugaku Zasshi; 2020; 140(1):63-79. PubMed ID: 31902887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model.
    Kaibuchi N; Iwata T; Yamato M; Okano T; Ando T
    Acta Biomater; 2016 Sep; 42():400-410. PubMed ID: 27326918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function.
    Elsayed R; Abraham P; Awad ME; Kurago Z; Baladhandayutham B; Whitford GM; Pashley DH; McKenna CE; Elsalanty ME
    Bone; 2018 May; 110():141-149. PubMed ID: 29408511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
    Endo Y; Kumamoto H; Nakamura M; Sugawara S; Takano-Yamamoto T; Sasaki K; Takahashi T
    Biol Pharm Bull; 2017; 40(6):739-750. PubMed ID: 28566618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronate induces osteonecrosis of the jaw in sheep.
    Voss PJ; Stoddart M; Ziebart T; Zeiter S; Nelson K; Bittermann G; Schmelzeisen R; Poxleitner P
    J Craniomaxillofac Surg; 2015 Sep; 43(7):1133-8. PubMed ID: 26154396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, OX14 (1-Fluoro-2-(Imidazo-[1,2-α]Pyridin-3-yl)-Ethyl-Bisphosphonate).
    Lawson MA; Ebetino FH; Mazur A; Chantry AD; Paton-Hough J; Evans HR; Lath D; Tsoumpra MK; Lundy MW; Dobson RL; Quijano M; Kwaasi AA; Dunford JE; Duan X; Triffitt JT; Jeans G; Russell RGG
    J Bone Miner Res; 2017 Sep; 32(9):1860-1869. PubMed ID: 28337806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates' antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D Matrigel assay.
    Pabst AM; Ziebart T; Ackermann M; Konerding MA; Walter C
    Clin Oral Investig; 2014 Apr; 18(3):1015-22. PubMed ID: 23892503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronate induces bisphosphonate-related osteonecrosis of the jaw in osteopenic sheep.
    Voss PJ; Stoddart MJ; Bernstein A; Schmelzeisen R; Nelson K; Stadelmann V; Ziebart T; Poxleitner PJ
    Clin Oral Investig; 2016 Jan; 20(1):31-8. PubMed ID: 25843053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of oral osteomucosal tissue constructs in vitro and localization of fluorescently-labeled bisphosphonates to hard and soft tissue.
    Bae S; Sun S; Aghaloo T; Oh JE; McKenna CE; Kang MK; Shin KH; Tetradis S; Park NH; Kim RH
    Int J Mol Med; 2014 Aug; 34(2):559-63. PubMed ID: 24920042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bisphosphonate-associated osteonecrosis of the jaw].
    Krauth MT; Fügl A; Gruber R
    Wien Klin Wochenschr; 2008; 120(15-16):467-76. PubMed ID: 18820850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasticity of Myeloid Cells during Oral Barrier Wound Healing and the Development of Bisphosphonate-related Osteonecrosis of the Jaw.
    Sun Y; Kaur K; Kanayama K; Morinaga K; Park S; Hokugo A; Kozlowska A; McBride WH; Li J; Jewett A; Nishimura I
    J Biol Chem; 2016 Sep; 291(39):20602-16. PubMed ID: 27514746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing or controlling periodontitis reduces the occurrence of osteonecrosis of the jaw (ONJ) in rice rats (Oryzomys palustris).
    Castillo EJ; Messer JG; Abraham AM; Jiron JM; Alekseyenko AV; Israel R; Thomas S; Gonzalez-Perez GM; Croft S; Gohel A; Bhattacharyya I; Yarrow JF; Novince CM; Kimmel DB; Aguirre JI
    Bone; 2021 Apr; 145():115866. PubMed ID: 33515777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of bisphosphonate on the remodeling of different irregular bones in mice.
    Su J; Feng M; Han W; Zhao H
    J Oral Pathol Med; 2015 Sep; 44(8):638-48. PubMed ID: 25370709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.